For this extra episode, we digest the positive news out this morning on one of the front runners for a viable vaccine against this latest coronavirus. What are the implications for the economy and investors? Phil Attreed (Head of Investment Consulting) speaks to Will Hobbs (Chief Investment Officer) and Jean-Paul Jaegers (Head of Asset Allocation).
